HOW TO INTEGRATE NEW DRUGS IN THE CURRENT THERAPEUTIC LANDSCAPE OF METASTATIC TRIPLE NEGATIVE BREAST...

Does molecular triage help to identify highly sensitive disease?

L. Pusztai

Please set the zoomlevel of your browser to 100%.